EORTC

Related by string. * * EORTC NCI AACR Symposium . EORTC NCI AACR . AACR NCI EORTC . AACR NCI EORTC Molecular . Cancer EORTC . #nd EORTC NCI . AACR EORTC NCI . EORTC QLQ C# . EORTC NCI *

Related by context. Frequent words. (Click for all words.) 71 RTOG 66 randomized Phase III 63 multicentre 62 ESMO 62 J Clin Oncol 62 National Surgical Adjuvant 61 Cooperative Oncology 61 noninferiority 61 multicenter study 61 Taxotere ® 61 placebo controlled clinical 61 neoadjuvant 61 Phase III randomized 61 AASLD 60 multicenter 60 AACR NCI EORTC 60 substudy 59 dose escalation trial 59 League Against Rheumatism 59 axitinib 59 multicenter clinical 59 Medical Oncology ESMO 59 multicenter randomized 59 prospective randomized controlled 59 randomized controlled clinical 59 phase IIa 58 prospective observational 58 Cancer Res 58 decitabine 58 Lenalidomide 58 antitumor activity 58 tocilizumab 58 EASL 58 sunitinib 58 Phase 2a trial 58 #:#-# [031] 58 relapsed refractory multiple myeloma 58 Chronic Lymphocytic Leukemia 57 Phase IIa trial 57 Phase 2b trial 57 HER2 positive metastatic breast 57 nab paclitaxel 57 Cardiology ESC 57 Phase 1b clinical 57 Phase Ib 57 phase IIb 57 metastatic renal cell carcinoma 57 Pharmacokinetic 57 tesmilifene 57 Clinical Oncology Annual Meeting 57 Clinical Trial Results 57 Abstract # 56 ECOG 56 EASD 56 ASCO Annual Meeting 56 Transcatheter Cardiovascular Therapeutics TCT 56 Phase 2b study 56 Myocardial Infarction 56 EULAR 56 aflibercept 56 CA4P 56 multicenter randomized double 56 randomized controlled clinical trials 56 ICAAC 56 clinical trial 56 neoadjuvant chemotherapy 56 Neck Cancer 56 seliciclib 56 subgroup analyzes 56 CAPRISA 56 Ann Intern Med 56 dose escalation study 56 virologic response 55 pazopanib 55 retrospective cohort study 55 chemoradiation 55 Torisel 55 FDG PET 55 CYT# 55 plus prednisone 55 relapsed refractory 55 Thoracic Oncology 55 Phase IIa clinical 55 Phase IIb trial 55 Bortezomib 55 TORISEL 55 ARVO 55 EpCAM 55 Respiratory Society 55 INGN 55 Alpharadin 55 clinical endpoints 55 FOLFIRI 55 randomized clinical 55 Phase 2a clinical 55 mCRC 55 hepatocellular carcinoma HCC 55 CATIE 55 secondary efficacy endpoints 55 IMGN# 54 San Antonio Breast Cancer

Back to home page